US Stock MarketDetailed Quotes

HAE Haemonetics

Watchlist
  • 62.360
  • +0.070+0.11%
Close Feb 14 16:00 ET
  • 62.360
  • 0.0000.00%
Post 17:01 ET
3.13BMarket Cap24.55P/E (TTM)

Haemonetics Key Stats

Haemonetics Q3 2025 Earnings Date

Currency:USDFeb 6, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
352.88M
348.54M
-4.34M
Miss Est.
+4.95%
+3.66%
-1.23%
EPS
0.91
0.74
-0.17
Miss Est.
+48.75%
+21.31%
-18.45%
Strong Buy

Feb 7, 2025

Haemonetics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2026/Q1-- / 319.161M--
--2025/Q4-- / 330.634M--
Feb 6, 20252025/Q3348.542M / 352.883M--
Nov 7, 20242025/Q2345.511M / 342.578M--
Aug 8, 20242025/Q1336.172M / 335.040M--
DatePeriodRevenue/EstimateEarnings Call
--2026/Q1-- / 319.161M--
--2025/Q4-- / 330.634M--
Feb 6, 20252025/Q3348.542M / 352.883M--
Nov 7, 20242025/Q2345.511M / 342.578M--
Aug 8, 20242025/Q1336.172M / 335.040M--

Unlock Free Earnings Estimates

Haemonetics Earnings Reports

Read more

Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Feb 7, 2025

Strong Buy

  • Buy

    77.78%
  • Hold

    22.22%
  • Sell

    0.00%

Price Target

No Data